Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Cartesian Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Murat Kalayoglu, Director (Form 8-K filed 2026-03-30). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Barclays PLC (filed 2026-08-13).
Who is behind it
Cartesian Therapeutics, Inc.: incorporated in Delaware; business address in Frederick, Maryland; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-13).
Officers and directors, each with the role and the filing that names them:
- Carsten Brunn: Executive Officer, Director (Form D, 2024-07-17)
- Blaine Davis: Executive Officer (Form D, 2024-07-17)
- Carrie S. Cox: Director (Form D, 2024-07-17)
- Timothy C. Barabe: Director (Form D, 2024-07-17)
- Nishan de Silva: Director (Form D, 2024-07-17)
- Murat Kalayoglu: Director (Form D, 2024-07-17)
- Kemal Malik: Director (Form D, 2024-07-17)
- Michael Singer: Director (Form D, 2024-07-17)
- Timothy A. Springer: Director (Form D, 2024-07-17)
- Patrick Zenner: Director (Form D, 2024-07-17)
- Metin Kurtoglu: Executive Officer (Form D, 2024-07-17)
- Milos Miljkovic: Executive Officer (Form D, 2024-07-17)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-13 | Barclays PLC | 5.99% |
| Schedule 13G/A, 2026-07-22 | Jpmorgan Chase & Co. | 4.8% |
| Schedule 13G/A, 2026-05-06 | Fmr LLC | 3% |
| Schedule 13D/A, 2026-04-02 | Murat Kalayoglu | 19.9% |
| Schedule 13G, 2026-03-13 | Squarepoint Ops LLC | 8.3% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 5.3% |
| Schedule 13G/A, 2025-11-05 | Fmr LLC | 8.3% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-03-30 | Murat Kalayoglu | Director | departed | 2026-03-31 |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-07-17 | $130.02M | $130.02M |
| Form D, 2023-12-01 | $60.25M | $60.25M |
Latest IPO step: Cartesian Therapeutics, Inc. amended its IPO registration (S-1/A, 2024-09-20).
IPO filings: S-1/A, 2024-09-20, S-1/A, 2024-09-09, S-1, 2024-08-02; ticker RNAC on Nasdaq Global Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/cartesian-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G, 2026-08-13 · Form D, 2024-07-17 · Form 8-K, 2026-03-30 · S-1/A, 2024-09-20
Who owns Cartesian Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/cartesian-therapeutics